GLRX2 and Miyoshi myopathy: Moreover, according to the molecular classification of MM [21], the proliferating (PR) molecular subtype that is associated with a poor prognosis and a bad response to treatments, is characterized by an overexpression of GLRX2/3 and PRDX6 mRNAs (Figure S2).